12 Nov 2018 11:30
12 November 2018
Cello Health plc
("Cello", the "Company", or the "Group")
Directorate Change
Cello Health plc (AIM: CLL), the global healthcare focused advisory group, is pleased to announce the appointment of Michele Luzi as Non-Executive Director with immediate effect.
Michele is an Advisory Partner of Bain and Company, the global management consultancy, and has served on its global Board. He joined Bain in 1990 and is now reducing his time commitment to the partnership. Since 2010 Michele has served on the Board of Midatech Pharma PLC, a UK Nanotechnology Biotech PLC. Michele is an Italian national.
Mark Scott, Chief Executive, commented: "We are delighted to have Michele on board. He brings with him first-hand experience of growing a global professional service business, as well as a wide knowledge of the healthcare sector. His contribution will be very helpful as we seek to expand Cello's global footprint."
Enquiries:
Cello Group | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Finance Director | |
Cenkos Securities | 0207 397 8900 |
Mark Connelly Harry Hargreaves |
Appendix
Full name (age) |
Michele Luzi (61) |
Current directorships / partnerships: |
ASHWICK DEVELOPMENTS LIMITED ASHWICK PROJECTS LIMITED BAINCOMPANY PARTNERS, L.P. JUBILEE FILM PARTNERSHIP LLP MIDATECH PHARMA PLC PROJECT 99 LIMITED ST JAMES MEDIA LLP VIESVI LIMITED |
Previous directorships / partnerships (in the last five years): |
MIDATECH LTD RMD TRAFFORD HOUSE 2000 LIMITED RMD TRAFFORD HOUSE LLP YELLOW SKY PUBLISHING LIMITED |
As at today's date, Mr Luzi does not hold any ordinary shares in the capital of the Company.
There are no further disclosures to be made pursuant to Schedule 2(g) of the AIM Rules for Companies in respect of Mr Luzi's appointment.